Posts Tagged ‘ Gynecare Prolift ’

Prolift Transvaginal Mesh Discontinued in U.S. Still Sold Worldwide, Why?

Jan 29th, 2013 | By
Prolift Transvaginal Mesh Discontinued in U.S. Still Sold Worldwide, Why?

by KATHY L. [Editors Note* Kathy L is not the real name of this author. She is involved in litigation and chooses to remain anonymous at this time. ] January 29, 2013 ~ Last June, Johnson & Johnson subsidiary Ethicon informed a judge in West Virginia of its intention to discontinue sales of four vaginal mesh
[continue reading...]



Day 8: Linda Gross v Ethicon, Prolift Launched Under FDA Radar

Jan 22nd, 2013 | By
Day 8: Linda Gross v Ethicon, Prolift Launched Under FDA Radar

January 22, 2013 ~ Much thanks to Courtroom View Network for access to the live court proceedings and graphics shown to the jury. The Prolift surgical mesh did not undergo any FDA approval before it was marketed in March 2005. Last June Ethicon, a division of Johnson & Johnson announced it was removing Prolift and
[continue reading...]



Day Two Ethicon Trial: What J&J Knew About Transvaginal Mesh and When

Jan 13th, 2013 | By
Day Two Ethicon Trial: What J&J  Knew About Transvaginal Mesh and When

January 12~ 2012 Thanks to Courtroom View Network for providing a live feed to MDND. Day two of Linda Gross v Ethicon trial in an Atlantic City court brought an Ethicon engineer to the stand who was presented with a mountain of internal company documents intended to show how safety and efficacy of the Prolift
[continue reading...]



Ethicon Trial Opening Statements Thursday

Jan 8th, 2013 | By
Ethicon Trial Opening Statements Thursday

January 8, 2013 ~ Jurors are being selected today for the first of 1,974 lawsuits to be heard in a New Jersey state court against Johnson & Johnson, maker of the Gynecare Prolift Pelvic Floor Repair System (here) transvaginal mesh. Plaintiff Linda Gross from Watertown, South Dakota and her lawyers argue that Ethicon, a division
[continue reading...]



Lawyer Comments on FDA’s Lapdog Authority

Jul 12th, 2012 | By
Lawyer Comments on FDA’s Lapdog Authority

Generally speaking, lawyers avoid talking to reporters. But in a July 10 press release (here), Henry G. Garrard III of Blasingame, Burch, Garrard & Ashley, P.C., an Athens, Georgia law firm, recounts what he’s told to Bloomberg News in a June 26, 2012 story (here). The story – how Johnson & Johnson continued to sell
[continue reading...]



Breaking News! Johnson & Johnson’s Ethicon Plans to Pull Plug on Four Transvaginal Meshes!

Jun 4th, 2012 | By
Breaking News! Johnson & Johnson’s Ethicon Plans to Pull Plug on Four Transvaginal Meshes!

June 4, 2012 ~ Breaking news!  Bloomberg is reporting (here) that Johnson & Johnson (J&J) has requested the paperwork to stop selling four different types of transvaginal mesh in the face of hundreds of lawsuits. The Ethicon unit of J & J told a federal judge in West Virginia that it has requested the official
[continue reading...]



Let the Trials Begin – C.R. Bard

May 7th, 2012 | By
Let the Trials Begin – C.R. Bard

May 7, 2012 ~ The date has been set  – February 5, 2013 will be the  first of what promises to be a series of federal court trials over vaginal mesh injuries in women implanted with synthetic mesh made by C.R. Bard Inc. Multidistrict litigation (MDL) No. 2187 is consolidated before U.S. District Judge Joseph
[continue reading...]



Breaking News ~ J & J Sold Vaginal Mesh Implant Without FDA Approval

Mar 21st, 2012 | By
Breaking News ~ J & J Sold Vaginal Mesh Implant Without FDA Approval

March 21 ~ Bloomberg is reporting (here) that major medical device maker Johnson & Johnson (J&J) sold the Gynecare Prolift surgical mesh for three years before it was approved by the U.S. Food and Drug Administration (FDA). The mesh is now the subject of more than 550 lawsuits, reports Bloomberg. Prolift is a pre-cut mesh
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.